JCI - Citations to Testing the NKT cell hypothesis of human IDDM pathogenesis

Citations to this article

Testing the NKT cell hypothesis of human IDDM pathogenesis

Peter T. Lee, … , Peter A. Gottlieb, Albert Bendelac

Peter T. Lee, … , Peter A. Gottlieb, Albert Bendelac

Published September 15, 2002
Citation Information: J Clin Invest. 2002;110(6):793-800. https://doi.org/10.1172/JCI15832.

View: Text | PDF

Article Immunology

Total citations by year

Year:	2024	2023	2022	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	Total
Citations:	1	1	2	1	1	3	2	3	10	3	8	7	11	3	9	4	7	1	4	6	2	1	90

Citation information

Citations to this article (90)

Title and authors	Publication	Year
Intestinal mucosal immunity and type 1 diabetes: Non‐negligible communication between gut and pancreas Liu R, Zhang J, Chen S, Xiao Y, Hu J, Zhou Z, Xie L	Diabetes, Obesity & Metabolism	2024
CD8+ T-cell immunity orchestrated by iNKT cells Qin Y, Bao X, Zheng M	Frontiers in immunology	2023
Multipurposing CARs: Same engine, different vehicles A Hossian, C Hackett, R Brentjens, S Rafiq	Molecular Therapy	2022
Are NKT cells a useful predictor of COVID-19 severity? H Koay, N Gherardin, T Nguyen, W Zhang, J Habel, R Seneviratna, F James, N Holmes, O Smibert, C Gordon, J Trubiano, K Kedzierska, D Godfrey	Immunity	2022
T Cell Responses to Mycobacterial Glycolipids: On the Spectrum of “Innateness” CA James, C Seshadri	Frontiers in immunology	2020
Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor P Humeniuk, S Geiselhart, C Battin, T Webb, P Steinberger, W Paster, K Hoffmann-Sommergrsuber	Scientific Reports	2019
Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells LC Garner, P Klenerman, NM Provine	Frontiers in immunology	2018
The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach D Krijgsman, M Hokland, PJ Kuppen	Frontiers in immunology	2018
Invariant Natural Killer T Cell Subsets—More Than Just Developmental Intermediates SH Krovi, L Gapin	Frontiers in immunology	2018
A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies M Waldowska, A Bojarska-Junak, J Roliński	CENT EUR J IMMUNOL	2017
Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective A Kumar, N Suryadevara, TM Hill, JS Bezbradica, LV Kaer, S Joyce	Frontiers in immunology	2017
CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control L Veinotte, S Gebremeskel, B Johnston	OncoImmunology	2016
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma? M Favreau, K Vanderkerken, D Elewaut, K Venken, E Menu	Oncotarget	2016
A new high-throughput sequencing method for determining diversity and similarity of T cell receptor (TCR) α and β repertoires and identifying potential new invariant TCR α chains K Kitaura, T Shini, T Matsutani, R Suzuki	BMC Immunology	2016
Regulation of NKT Cell Localization in Homeostasis and Infection D Slauenwhite, B Johnston	Frontiers in immunology	2015
iNKT and MAIT Cell Alterations in Diabetes I Magalhaes, B Kiaf, A Lehuen	Frontiers in immunology	2015
Reduced iNKT cells numbers in type 1 diabetes patients and their first-degree relatives: Familial low NKT cells in T1D N Beristain-Covarrubias, E Canche-Pool, R Gomez-Diaz, LE Sanchez-Torres, V Ortiz-Navarrete	Immunity, Inflammation and Disease	2015
Regulatory role of natural killer T cells in diabetes C Tard, O Rouxel, A Lehuen	Biomedical journal	2015
Immunogenetics of type 1 diabetes mellitus MP Morran, A Vonberg, A Khadra, M Pietropaolo	Molecular Aspects of Medicine	2015
A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells SW Tsaih, M Presa, S Khaja, AE Ciecko, DV Serreze, YG Chen	Genes and Immunity	2015
The transcriptional programs of iNKT cells EY Kim, L Lynch, PJ Brennan, NR Cohen, MB Brenner	Seminars in Immunology	2015
Preserved Function of Circulating Invariant Natural Killer T Cells in Patients With Chronic Hepatitis B Virus Infection: H Zhu, Y Zhang, H Liu, Y Zhang, Y Kang, R Mao, F Yang, D Zhou, J Zhang	Medicine	2015
Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response YJ Lee, H Wang, GJ Starrett, V Phuong, SC Jameson, KA Hogquist	Immunity	2015
Antigen specificity of invariant natural killer T-cells AM Birkholz, M Kronenberg	Biomedical journal	2015
Mycobacterium Tuberculosis-Specific Memory NKT Cells in Patients with Tuberculous Pleurisy Z Li, B Yang, Y Zhang, J Ma, X Chen, S Lao, B Li, C Wu	Journal of Clinical Immunology	2014
Potential Role of IL-17-Producing iNKT Cells in Type 1 Diabetes S Li, C Joseph, C Becourt, J Klibi, S Luce, D Dubois-Laforgue, E Larger, C Boitard, K Benlagha, F Trottein	PloS one	2014
Different subsets of natural killer T cells may vary in their roles in health and disease V Kumar, TL Delovitch	Immunology	2014
Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes MJ Clemente, B Przychodzen, A Jerez, BE Dienes, MG Afable, H Husseinzadeh, HL Rajala, MW Wlodarski, S Mustjoki, JP Maciejewski	Blood	2013
Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions SW Tsaih, S Khaja, AE Ciecko, E MacKinney, YG Chen	Genes and Immunity	2013
Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus AE Tabarrozzi, CN Castro, RA Dewey, MC Sogayar, L Labriola, MJ Perone	Clinical & Experimental Immunology	2013
Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Y Simoni, J Diana, L Ghazarian, L Beaudoin, A Lehuen	Clinical & Experimental Immunology	2013
Analyzing antigen recognition by Natural Killer T cells S Zeissig, T Olszak, E Melum, RS Blumberg	Methods in molecular biology (Clifton, N.J.)	2013
Invariant natural killer T cells in children with eosinophilic esophagitis S Jyonouchi, CL Smith, F Saretta, V Abraham, KR Ruymann, P Modayur-Chandramouleeswaran, ML Wang, JM Spergel, A Cianferoni	Clinical & Experimental Allergy	2013
Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis JE Snyder-Cappione, DF Nixon, JC Chi, ML Nguyen, CK Kirby, JM Milush, LL Koth	European Journal of Immunology	2013
Polymorphisms in the CD1d Promoter That Regulate CD1d Gene Expression Are Associated with Impaired NKT Cell Development ZD Borg, PJ Benoit, GW Lilley, I Aktan, A Chant, VL DeVault, M Rincon, JE Boyson	Journal of immunology (Baltimore, Md. : 1950)	2013
CD1d-restricted NKT cell function prevents insulin resistance in lean mice, and is regulated by adipocytes Henk Schipper, Maryam Rakhshandehroo, Stan Van de Graaf, Koen Venken, Arjen Koppen, Rinke Stienstra, Serge Prop, Jenny Meerding, Nicole Hamers, Gurdyal Besra, Louis Boon, Edward Nieuwenhuis, Dirk Elewaut, Berent Prakken, Sander Kersten, Marianne Boes, Eric Kalkhoven	Journal of Clinical Investigation	2012
The Majority of CD1d-Sulfatide Specific T Cells in Human Blood Use a Semi-Invariant Vδ1 TCR L Bai, D Picard, B Anderson, V Chaudhary, A Luoma, B Jabri, EJ Adams, PB Savage, A Bendelac	European Journal of Immunology	2012
Prevention and treatment of type 1 diabetes mellitus by the manipulation of invariant natural killer T cells J Novak, L Novakova	Clinical and Experimental Medicine	2012
Lipid-Antigen Presentation by CD1d+ B Cells Is Essential for the Maintenance of Invariant Natural Killer T Cells A Bosma, A Abdel-Gadir, DA Isenberg, EC Jury, C Mauri	Immunity	2012
Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells: Reduced circulating iNKT cells in non-segmental vitiligo L Zhou, K Li, YL Shi, I Hamzavi, TW Gao, M Henderson, RH Huggins, O Agbai, B Mahmoud, X Mi, HW Lim, QS Mi	Pigment Cell & Melanoma Research	2012
Interruption of CXCL13-CXCR5 Axis Increases Upper Genital Tract Pathology and Activation of NKT Cells following Chlamydial Genital Infection J Jiang, O Karimi, S Ouburg, CI Champion, A Khurana, G Liu, A Freed, J Pleijster, N Rozengurt, JA Land, HM Surcel, A Tiitinen, J Paavonen, M Kronenberg, SA Morré, KA Kelly, DM Ojcius	PloS one	2012
ZBTB7B (Th-POK) Regulates the Development of IL-17–Producing CD1d-Restricted Mouse NKT Cells A Enders, S Stankovic, C Teh, AP Uldrich, M Yabas, T Juelich, JA Altin, S Frankenreiter, H Bergmann, CM Roots, K Kyparissoudis, CC Goodnow, DI Godfrey	Journal of immunology (Baltimore, Md. : 1950)	2012
Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay J Diana, V Brezar, L Beaudoin, M Dalod, A Mellor, A Tafuri, M Herrath, C Boitard, R Mallone, A Lehuen	Journal of Experimental Medicine	2011
Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice HJ Blumenfeld, R Tohn, SM Haeryfar, Y Liu, PB Savage, TL Delovitch	Clinical & Experimental Immunology	2011
Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type YG Chen, SW Tsaih, DV Serreze	Genes and Immunity	2011
Dynamics of Non-conventional Intraepithelial Lymphocytes—NK, NKT, and γδ T—in Celiac Disease: Relationship with Age, Diet, and Histopathology S Calleja, S Vivas, M Santiuste, L Arias, M Hernando, E Nistal, J Casqueiro, JG de Morales	Digestive Diseases and Sciences	2011
The split personality of NKT cells in malignancy, autoimmune and allergic disorders JJ Subleski, Q Jiang, JM Weiss, RH Wiltrout	Immunotherapy	2011
Control of early stages in invariant natural killer T-cell development T Hu, I Gimferrer, J Alberola-Ila	Immunology	2011
Distinct and Overlapping Effector Functions of Expanded Human CD4+, CD8α+ and CD4-CD8α- Invariant Natural Killer T Cells V O'Reilly, SG Zeng, G Bricard, A Atzberger, AE Hogan, J Jackson, C Feighery, SA Porcelli, DG Doherty	PloS one	2011
A naive-like population of human CD1d-restricted T cells expressing intermediate levels of PLZF MG Constantinides, D Picard, AK Savage, A Bendelac	Journal of immunology (Baltimore, Md. : 1950)	2011
Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine T Orban, JT Kis	Therapeutic Advances in Endocrinology and Metabolism	2011
Invariant natural killer T cells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin S Jyonouchi, V Abraham, JS Orange, JM Spergel, L Gober, E Dudek, R Saltzman, KE Nichols, A Cianferoni	Journal of Allergy and Clinical Immunology	2011
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis AE Hogan, AM Tobin, T Ahern, MA Corrigan, G Gaoatswe, R Jackson, V O’Reilly, L Lynch, DG Doherty, PN Moynagh, B Kirby, J O’Connell, D O’Shea	Diabetologia	2011
Human abetalipoproteinemia as an immune disease involving CD1 Sebastian Zeissig, Stephanie Dougan, Duarte Barral, Yvonne Junker, Zhangguo Chen, Arthur Kaser, Madelyn Ho, Hannah Mandel, Adam McIntyre, Susan Kennedy, Gavin Painter, Natacha Veerapen, Gurdyal Besra, Vincenzo Cerundolo, Simon Yue, Sarah Beladi, Samuel Behar, Xiuxu Chen, Jenny Gumperz, Karine Breckpot, Anna Raper, Amanda Baer, Mark Exley, Robert Alexander Hegele, Marina Cuchel, Daniel J. Rader, Nicholas Davidson, Richard Blumberg	Journal of Clinical Investigation	2010
Raising the NKT cell family DI Godfrey, S Stankovic, AG Baxter	Nature Immunology	2010
A Comprehensive Ex Vivo Functional Analysis of Human NKT Cells Reveals Production of MIP1-α and MIP1-β, a Lack of IL-17, and a Th1-Bias in Males JE Snyder-Cappione, C Tincati, IG Eccles-James, AJ Cappione, LC Ndhlovu, LL Koth, DF Nixon, D Unutmaz	PloS one	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Checkpoints in lymphocyte development and autoimmune disease H von Boehmer, F Melchers	Nature Immunology	2009
A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes F Scheuplein, B Rissiek, JP Driver, YG Chen, F Koch-Nolte, DV Serreze	Journal of Autoimmunity	2009
Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency DA Fulcher, DT Avery, NL Fewings, LJ Berglund, S Wong, DS Riminton, S Adelstein, SG Tangye	Clinical & Experimental Immunology	2009
Where do MAIT cells fit in the family of unconventional T cells? L Gapin	PLoS Biology	2009
Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family AC Chan, L Serwecinska, A Cochrane, LC Harrison, DI Godfrey, SP Berzins	Clinical & Experimental Immunology	2009
Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens P Arrenberg, R Halder, V Kumar	Journal of Cellular Physiology	2009
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy P Thapa, G Zhang, C Xia, A Gelbard, WW Overwijk, C Liu, P Hwu, DZ Chang, A Courtney, JK Sastry	Vaccine	2009
The contrasting roles of NKT cells in tumor immunity. Berzofsky JA, Terabe M	Current molecular medicine	2009
The role of NKT cells in tumor immunity M Terabe, JA Berzofsky	Advances in cancer research	2008
Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections JS Im, TJ Kang, SB Lee, CH Kim, SH Lee, MM Venkataswamy, ER Serfass, B Chen, PA Illarionov, GS Besra, WR Jacobs, GT Chae, SA Porcelli	Clinical Immunology	2008
CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system JL Matsuda, T Mallevaey, J Scott-Browne, L Gapin	Current Opinion in Immunology	2008
Widespread natural variation in murine natural killer T-cell number and function SL Rymarchyk, H Lowenstein, J Mayette, SR Foster, DE Damby, IW Howe, I Aktan, RE Meyer, ME Poynter, JE Boyson	Immunology	2008
The Development and Application of HLA Tetramers in the Detection, Characterization and Therapy of Type 1 Diabetes Mellitus HW Chen, SJ Liu, P Chong, C Sia	The review of diabetic studies : RDS	2007
"Persistence of Diabetes" - Why Has Research into Type 1 Diabetes not Made Significant Advances? C Sia, M Weinem	The review of diabetic studies : RDS	2007
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11 CJ Montoya, D Pollard, J Martinson, K Kumari, C Wasserfall, CB Mulder, MT Rugeles, MA Atkinson, AL Landay, SB Wilson	Immunology	2007
Translational Mini-Review Series on Type 1 Diabetes: Immune-based therapeutic approaches for type 1 diabetes T Staeva-Vieira, M Peakman, M Herrath	Clinical & Experimental Immunology	2007
Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis MD Gober, R Fishelevich, Y Zhao, D Unutmaz, AA Gaspari	Journal of Investigative Dermatology	2007
Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation G Gigli, S Caielli, D Cutuli, M Falcone	Immunology	2007
Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. El Haj M, Ben Ya'acov A, Lalazar G, Ilan Y	World Journal of Gastroenterology	2007
The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice SL Cardell	Clinical & Experimental Immunology	2006
Natural killer T cells and rheumatoid arthritis: friend or foe? D Elewaut	Arthritis Research & Therapy	2005
Involvement of sulfatide in beta cells and type 1 and type 2 diabetes K Buschard, M Blomqvist, T Osterbye, P Fredman	Diabetologia	2005
Regulatory T cells and type 1 diabetes. Bisikirska BC, Herold KC	Current Diabetes Reports	2005
Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes. Hussain S, Wagner M, Ly D, Delovitch TL	Immunologic research	2005
Going both ways: Immune regulation via CD1d-dependent NKT cells DI Godfrey, M Kronenberg	Journal of Clinical Investigation	2004
Immunoregulatory defects of V alpha 24V+ beta 11+ NKT cells in development of Wegener's granulomatosis and relapsing polychondritis D Takagi, K Iwabuchi, C Iwabuchi, Y Nakamaru, S Maguchi, R Ohwatari, Y Furuta, S Fukuda, S Joyce, K Onoé	Clinical & Experimental Immunology	2004
Type 1 diabetes and NKT cells: a report on the 3rd International Workshop on NKT cells and CD1-mediated antigen presentation, September 2004, Heron Island, QLD, Australia JM Fletcher, MA Jordan, AG Baxter	The review of diabetic studies : RDS	2004
The role of innate immunity in autoimmunity JF Bach, A Bendelac, MB Brenner, H Cantor, GD Libero, M Kronenberg, LL Lanier, DH Raulet, MJ Shlomchik, MG von Herrath	Journal of Experimental Medicine	2004
Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity L Poirot, C Benoist, D Mathis	Proceedings of the National Academy of Sciences	2004
An integrated view of suppressor T cell subsets in immunoregulation. Jiang H, Chess L	Journal of Clinical Investigation	2004
Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rabinovitch A, Suarez-Pinzon WL	Reviews in endocrine & metabolic disorders	2003
Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics. Sim BC, Holmberg K, Sidobre S, Naidenko O, Niederberger N, Marine SD, Kronenberg M, Gascoigne NR	Immunogenetics	2003
Do NKT cells control autoimmunity Lucienne Chatenoud	Journal of Clinical Investigation	2002

Advertisement